Stockreport

Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status [Yahoo! Finance]

Better Therapeutics, Inc.  (BTTX) 
PDF Designation from the FDA to treat people with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH. The breakthrough status is significant f [Read more]